Is It Too Late to Buy Microsoft Stock Now?

Category: Finance

Microsoft's stock has surged 466,000% since its IPO in 1986, driven by its strong position in technology and significant investments in AI and cloud computing. The company reported a 17% revenue increase in Q3 2024, with notable growth in its productivity and intelligent cloud segments. The acquisition of Activision Blizzard has further boosted its gaming revenue. Despite high valuation metrics, Microsoft's consistent growth and expansion in key markets suggest it remains a viable long-term investment.

Keywords: Microsoft, stock market, artificial intelligence

Source: The Motley Fool

Update At: 7/19/2024

Related Sources

Kinsale Capital Group Inc. Purchases 5,180 Shares of Johnson & Johnson (NYSE:JNJ)

Kinsale Capital Group Inc. raised its stake in Johnson & Johnson by 20.9% during the first quarter. Various institutional investors and hedge funds have also bought and sold shares of the company. Equities analysts have provided ratings and price targets for JNJ stock. Johnson & Johnson reported earnings exceeding estimates and increased its quarterly dividend. The company operates in the healthcare field globally.

MarketBeat

Johnson & Johnson (NYSE:JNJ) Shares Acquired by Redmond Asset Management LLC

Redmond Asset Management LLC increased its stake in Johnson & Johnson by 0.4% in the first quarter. The institutional investor now owns 33,754 shares of the company's stock. Johnson & Johnson's stock is valued at $5,340,000 in Redmond Asset Management LLC's investment portfolio. Various other hedge funds have also made changes to their positions in the stock. Johnson & Johnson's stock opened at $149.24 on Tuesday with a market capitalization of $359.17 billion. The company has received multiple ratings from investment analysts, with a consensus rating of 'Moderate Buy' and an average target price of $174.07.

American Banking and Market News

Commonwealth Retirement Investments LLC Has $6.65 Million Position in Johnson & Johnson (NYSE:JNJ)

Commonwealth Retirement Investments LLC increased its holdings in Johnson & Johnson by 19.5% during the first quarter, owning 42,063 shares worth $6,654,000. Other investors also made changes to their positions. Johnson & Johnson's stock details include opening at $149.69, market capitalization of $360.26 billion, and a quarterly dividend increase to $1.24. Analysts have issued various ratings on JNJ stock, with a consensus rating of 'Moderate Buy' and an average target price of $174.07.

American Banking and Market News

Sfmg LLC Buys 327 Shares of Johnson & Johnson (NYSE:JNJ)

Sfmg LLC increased its stake in Johnson & Johnson by 2.3% in the 1st quarter, with a total of 14,344 shares worth $2,269,000. Various other institutional investors and hedge funds also adjusted their positions in JNJ. Analyst reports on JNJ have varied, with price targets and ratings from different financial institutions. Johnson & Johnson's recent earnings report exceeded expectations, with $2.71 earnings per share for the quarter. The company's revenue was slightly higher than the consensus estimate. Johnson & Johnson operates in the healthcare sector, offering products in various therapeutic areas globally.

American Banking and Market News

Essex LLC Has $5.09 Million Stake in Johnson & Johnson (NYSE:JNJ)

Essex LLC reduced its position in shares of Johnson & Johnson by 1.2% in the 1st quarter. Several institutional investors have adjusted their stakes in JNJ. Research analysts have provided ratings and price targets for the stock. Johnson & Johnson's stock performance, financial data, and recent quarterly earnings are discussed.

American Banking and Market News

Johnson & Johnson (NYSE:JNJ) Shares Bought by Concurrent Investment Advisors LLC

Concurrent Investment Advisors LLC increased its stake in Johnson & Johnson by 0.8% in the first quarter. Other hedge funds also modified their holdings. Johnson & Johnson's stock details, including market capitalization, PE ratio, and ratings by various brokerages, are provided. The article also discusses the company's products and segments.

American Banking and Market News

Johnson & Johnson (NYSE:JNJ) Shares Purchased by Bey Douglas LLC

Bey Douglas LLC increased its holdings in Johnson & Johnson by 4.6% during the first quarter, with a total of 1,826 shares worth $289,000. Various other institutional investors also adjusted their stakes in JNJ. The stock opened at $149.24 with a market cap of $359.17 billion. Analysts have provided ratings and price targets for JNJ, with a consensus rating of 'Moderate Buy' and an average target price of $174.07.

American Banking and Market News

Johnson & Johnson (NYSE:JNJ) Shares Acquired by Grandfield & Dodd LLC

Grandfield & Dodd LLC increased its stake in Johnson & Johnson by 0.9% during the 1st quarter, according to its most recent Form 13F filing with the SEC. Other hedge funds have also modified their holdings of the company. Several research analysts have weighed in on the company, providing ratings and price targets. Johnson & Johnson stock opened at $149.88 on Friday, with a market cap of $360.71 billion. The company reported $2.71 earnings per share for the quarter, beating analysts' consensus estimates. Johnson & Johnson also announced a quarterly dividend increase.

American Banking and Market News

Sei Investments Co. Increases Position in Johnson & Johnson (NYSE:JNJ)

Sei Investments Co. increased its holdings in Johnson & Johnson by 9.9% in the 1st quarter. Other large investors also bought and sold shares of the company. Johnson & Johnson stock opened at $149.24 on Tuesday with a market cap of $359.17 billion. Analysts have provided various ratings for the stock. Johnson & Johnson researches, develops, and sells healthcare products worldwide.

American Banking and Market News

Texas Permanent School Fund Corp Buys 578 Shares of Johnson & Johnson (NYSE:JNJ)

Texas Permanent School Fund Corp increased its holdings in Johnson & Johnson during the 1st quarter. The company's stock is part of the fund's portfolio as the 20th largest holding. Various institutional investors have also adjusted their positions in the company. Johnson & Johnson's stock performance, market capitalization, dividend information, and analyst ratings are detailed in the article.

American Banking and Market News